# UPADACITINIB
> **ANDA218792** · Abbreviated New Drug Application (Generic) · Sponsor: SANDOZ INC · Approved 2025-11-14
## Drug
- **FDA Application Number:** ANDA218792
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** UPADACITINIB
- **Generic name:** Upadacitinib
- **Active ingredients:** UPADACITINIB
- **Dosage form:** TABLET, EXTENDED RELEASE
- **Route:** —
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** SANDOZ INC
- **First approval:** 2025-11-14
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218792)
---
*AI Analytics · CC0 1.0*